Understanding how IFNγ and the microenvironment affect ccRCC metabolism and signaling pathways may provide the necessary knowledge for the development of biomarkers of efficacy for therapies modulating the TME, such as immunotherapies. Here, IFNG is linked to nonpapillary renal cell carcinoma.